Ocular Therapeutix Stock (NASDAQ: OCUL) stock price, news, charts, stock research, profile.
Open | $9.07 |
Close | $8.98 |
Volume / Avg. | 4.27M / 1.48M |
Day Range | $8.83 - $9.16 |
52 Wk Range | 2.00 - 11.31 |
Market Cap | $1.40B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 11.82% |
Days to Cover | 23.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and ANI Pharmaceuticals (NASDAQ:ANIP).
There is no analysis for Ocular Therapeutix to provide a consensus price target.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $8.98 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix does not have any upcoming earnings scheduled.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.